GC Corporation (Kiyotaka Nakao, President & CEO, Bunkyo-ku, Tokyo) and group company Showa Yakuhin Kako Co., Ltd. (Seiji Yoshida, CEO, Chuo-ku Tokyo) started a project to construct a new manufacturing building for dental products in January 2018. The construction of the new manufacturing plant for sterile pharmaceutical products was completed as planned on June 5, 2019 (three-story building with total floor of 5,339.23㎡, located in Kawasaki-shi, Kanagawa-ken).
The completion ceremony was attended by many guests including Dr. Toshihiko Makino, Vice-President and Dr. Shigeo Sugiyama, Standing Director from the Japan Dental Association, Mr. Shigeo Nakayama Chairman of the Japan Dental Pharmaceutical Association, and Mr. Hikaru Ouchi, President of AYUMI Pharmaceutical Corporation. The guests also joined the Shinto ritual ceremony “Tamagushi-hoten”.
After the ritual ceremony, Yoshimasa Suzuki, Director of GC Corporation, gave a presentation by using a board, introducing the facilities of the new plant.
At the “Naorai”, a feast after the ritual ceremony, President Kiyotaka Nakao expressed gratitude to everyone involved in the construction project, for an on-time completion of the sterile pharmaceutical products manufacturing plant, which required highly-controlled environment. He also stated that GC Group would contribute to dental care not only in Japan but also around the world by delivering safe and reliable products with the best quality and in the best condition, from the new plant with cutting-edge facilities.
In his congratulatory speech, Dr. Toshihiko Makino, Vice-President of the Japan Dental Association said that he hoped the products manufactured in the top-level aseptic area would accelerate the realization of safe and secure dental care, representing an aim of the JDA.
Production will start at the new plant, positioned as a major manufacturing base for dental pharmaceutical products in GC group, targeting to contribute to dentistry both in Japan and world-wide.
GC has positioned the 21st century as a “Century of Health” and is challenging to become the No. 1 dental company of the world supporting and improving people’s life through dental care.
We will continue our concerted group-wide efforts to contribute to people’s health and smiles around the world. Your continued support would be much appreciated.
